Introduction
Retinoids are key biological regulators involved in the growth, dierentiation and apoptosis of various normal and malignant cells (reviewed by Gudas et al., 1994) . Strikingly, the action of retinoids in these biological responses is either activation or inhibition depending on both the cell type and its environmental context. This suggested an important role for cross-talk between retinoid and other signalling pathways, including cell membrane signalling pathways (reviewed by Gudas et al., 1994 . Direct or indirect regulation of gene expression is generally proposed as the molecular mechanism by which these pleiotropic biological responses are generated.
Biological responses to retinoids are currently used therapeutically in various pathologies (see Hong and Itri, 1994; Peck and DiGiovanna, 1994) . In t(15;17) acute promyelocytic leukaemia (APL) (Rowley et al., 1977; Borrow et al., 1990; de TheÂ et al., 1990) , all-trans retinoic acid (RA) triggers cell maturation of leukaemic clones (Huang et al., 1988) . Strikingly, however, it has been observed both in vivo and in vitro that retinoids are enhancing cell proliferation while growth arrest occurs suddenly at a latter stage. Hyperleukocytosis which results primarily from hyperproliferation of blasts cells induced by retinoids represents a severe complication of retinoid therapy (Castaigne et al., 1990; Sakashita et al., 1993; Frankel et al., 1992; Grignani et al., 1994) . The molecular basis of this phenomenon is unknown. It is therefore crucial to have a further understanding of this biphasic response to RA.
NB4 cells were used as an in vitro model to study the APL cell response to retinoids (Lanotte et al., 1991) . In RA-treated NB4 cells, the enhanced cell proliferation is observed between 24 ± 72 h and a sudden growth arrest follows. In order to identify novel genes involved in cell growth regulation, the mRNAs dierentially expressed during the RA-induced proliferative stage were systemically analysed by the PCR-based Dierential Display technique (Liang and Pardee, 1992) . Several novel cDNA sequences have been identi®ed and those of interest were selected based upon peptide motifs previously identi®ed on gene products implicated in signal transduction. Our search has been focused on eector components of novel signal transduction pathways (membrane receptors, transducing enzymes, nuclear factors). Novel sequences with structural homologies to nuclear factors were identi®ed. Here we report the isolation, cloning and characterization of JEM-1, a novel leucine zipper gene upregulated by retinoids during the proliferative phase that precedes NB4 cell maturation. The structural features of JEM-1 and its pattern of expression suggest several levels of regulation.
Using the PCR-ampli®ed cDNA fragment (Figure 1a , b) as a probe, a dierential expression of a 3.0 kb transcript was detected on Northern blot (Figure 1c ) supporting the pattern shown on the electrophoretic dierential display. A l-ZAP II phagemid cDNA library from RA-treated NB4 cells was constructed, then screened with the cDNA fragment as a probe to obtain larger Jem-related clones. Total cDNA (2728 bp) has been sequenced (Figure 1d ).
Structural features of Jem cDNA and protein
The algorithmic analysis of the sequence indicates an ATG (position 402, Figure 1d ) in a reasonable context to serve as initiation codon, according to Kozak (1987) , and a OCH codon at the position 1602. In addition, the 5' untranslated region (5'UTR) contains typical SP1 enhancer consensus sequence (position 237 ± 246). The 3'UTR of the Jem cDNA shows three consensus polyadenylation signal sequences (Simonsen and Levinson, 1983 ) (AATAAA, indicated in bold in Figure 1d ). The largest potential open reading frame (ORF) encodes a 400 amino acid polypeptide with a predicted molecular mass of 45 kDA. Calculated from the a.a. sequence the isoelectric point is 8.9. In Figure  1e and f are shown the main motifs present on Jem cDNA with a detailed analysis of the ORF. A 30 a.a. domain (172 to 203) with a predicted a-helix structure contains a heptade of ®ve leucine residues (an authentic leucine-zipper' dimerisation motif (underlined); ®ve leucines (bold) in positions 173, 180, 187, 194, 201 ; see in Figure 1d ), but with only limited homology with transcription factors like AP-1 and CREB/ATF (Busch and Sassone-Corsi, 1990) , or also with the L-zipper gene MEQ of Marek disease virus (Jones et al., 1992) . Jem leucine zipper has the same spacing as these transcription factors and shows also charged residues reported to stabilise the a-helical structure of these proteins (Figure 1f ). These features are compatible with heterodimerisation.
This leucine-zipper motif is inserted in a 83 a.a. stretch compatible with an uninterrupted a-helix structure. No typical basic domain was found close to this leucine-zipper, but upstream a 29 a.a. stretch contains several repeats of basic residues (doubleunderlined in Figure 1d ). This region shows some homology with DNA-binding domains of transcription factors like AP-1 and CREB/ATF (Figure 1f ). In addition several conserved basic residues are shared by C/EBP and JEM. Homology at several typical position for basic or hydrophobic residues is missing. It is not excluded however that this region could bind to a speci®c consensus DNA sequence not yet identi®ed. This`basic' region and the zipper region are separated by a hinge region. Jem hinge region spans for exactly 14 residues without proline which ideally ®ts with four a-helix turns. This is consistent with the scissors-grip model of DNA binding proposed for bZIP proteins (Vinson et al., 1989) which implies that the hinge region has to keep a correct helix register for the basic domain to contact DNA eectively. The length of the Jem hinge region corresponds to that of C/EBP and is twice the length of the AP-1 spacer. Several putative (PKA, PKC, GSK3, CK-II) phosphorylation sites are detected (see in Figure 1e ). Finally, a typical PEST motif (Rogers et al., 1986 ) is identi®ed at the COOH end of JEM (position 351 to 365, bold and underlined in Figure 1d ).
Southern blot identi®cation and chromosome mapping of Jem gene
The presence of the Jem DNA sequence in the NB4 cell genome was con®rmed by Southern-blot (Figure 2a) , as well as in the avian and mammalian genomes ( Figure  2b ), using XbaI ± SacI digested Jem cDNA as a probe. Notice a faint band in chicken DNA. No signal was detected in yeast DNA. The location of Jem gene on the human chromosome 1 at the position q24 was demonstrated by FISH analysis (see in Figure 2c ).
Expression of Jem mRNA in normal and leukaemia cells
Cells were treated with the RA-receptor pan-agonists (all-trans-RA and 9-cis-RA) inducing NB4 cell maturation. Maturation-resistant NB4-R1 cells were used as a negative control. Northern blot analysis of RA timecourse treatment of NB4 cells shows that a JEM transcript of 2.8 ± 3.0 kb (probed with Jem cDNA) was strongly upregulated by retinoids (all-trans and 9-cis RA) with a peak of expression at 48 ± 72 h (Figure 3a ) during the proliferative phase immediately preceding growth arrest and morphological maturation. We noticed however that Jem probe also hybridized with a faint band close to, or slightly higher than 3.0 kb in size. This band was detected in untreated NB4 control and in NB4-R1 cells (Ruchaud et al., 1994) , but was never upregulated by RA. The nature of this larger transcript is yet unclear. No upregulation of Jem was obtained with any retinoids in maturation-resistant NB4-R1 cells. A panel of non-APL leukaemia cell lines was used to determine whether Jem was constitutively expressed in other leukemic cells. Jem mRNA was expressed in several cell lines independently of RAstimulation (Figure 3b) . A weak expression was observed in some T-cell leukaemia (not shown) while a strong expression was observed in pro-B (Nalm 16), pre-B (697, Nalm 6), myeloma (RPMI-8226) and plasmocytoma (LP-1) cell lines. Burkitt's lymphoma cells (Daudi, Raji) were negative. Jem was also detected in normal adrenal cells suggesting that its expression is not restricted to the hemopoietic system.
In vivo and in vitro transcription-translation identify Jem as a novel p45 basic leucine-zipper nuclear factor
The total cDNA was used as template for in vitro transcription and translation with the T3 RNApolymerase/rabbit reticulocyte lysate (see in legend to Jem-1 nuclear factor cDNA E Duprez et al (45 ± 46 kDa) apparent molecular weight is not clearly understood. The lower than expected m.w. of the in vitro generated Jem product may result from a preferential initiation at an internal ATG codon at the position +24 (not shown). The in situ localisation of the epitope-tagged Jem protein in transfected COS-7 cells clearly indicated that Jem shows a typical nuclear localisation. Jem showed a ponctuated pattern of expression in the nucleus. At low level of expression it was observed as numerous ®ne dots (not shown), while it also formed large nuclear ponctuation associated to chromatin when highly expressed (Figure 4c ). In this case, large ponctuations were more often associated with chromatin at the periphery of the nuclei. Jem was absent in nucleoli ( Figure 4c ). No Jem protein was detected in the cytoplasm. An imperfect basic bipartite motif (Figure 1d ± f) , is a possible candidate for a nuclear localisation signal (NLS) (Digman and Roeder, 1983) used to drive the Jem protein towards the nucleus. That this motif contained in its vicinity several possible sites for phosphorylation could indicate a nuclear localisation dependent on cell signalling (Hunter and Karin, 1992) .
Discussion
We have identi®ed, cloned and characterised JEM, a novel transcribed locus mapped on human chromosome 1 at q42. No chromosomal translocation or deletion have been identi®ed at this locus. The most notable feature of JEM protein is that it belongs to the family of b-ZIP nuclear factors. Importantly the Jem transcript is detectable in cell lines derived from several hematopoietic pathologies, and is upregulated during the proliferative stage that precedes RA-induced cell maturation in NB4 cells.
The structural analysis and the pattern of Jem expression provide the framework for further investigations. The ®nding of a primary structure compatible with a leucine-zipper and a nuclear localisation may suggest an interaction of Jem protein with the nuclear matrix and/or the formation of homo-or hererodimers, particularly with transcription factors. It may have as yet unknown partners with higher L-zipper structural complementarity. JEM-1 could be a member of a new family of nuclear proteins and the search for partners is now an important issue.
Several levels of regulation of JEM can be envisaged. The RA-induced JEM mRNA upregulation in NB4 cells is correlated to cell proliferation, while its late decreased expresssion is associated to growth arrest and maturation. Jem protein level can also be subjected to post-translation control. Ubiquitin-proteasome proteolysis of Jem (Ciechanover, 1994 ) is a likely hypothesis since, like Fos and other short-lived proteins, Jem features a long PEST motif in its Cterminal end. That this PEST motif is¯anked upstream by a consensus motif for several protein kinases (casein-Kinase II, PKA and GSK3) at a position with signi®cant surface probability suggested that JEM stability might also be regulated by phosphorylation (Tsurumi et al., 1995) . Regulation of Jem function by post-translational modi®cation is also a possibility. Several putative consensus motifs for PKA, PKC and GSK3 (like for c-jun and CREB)¯anking the basic region or scattered at the N-terminal end, indicate that the regulation of JEM function by cell membrane signalling via phosphorylation has to be investigated. Therefore, Jem oers several potential mechanisms for cross-talk.
The physiological context of Jem expression has to be analysed to determine whether it is associated with discrete pathologies. Apart from data demonstrating that Jem is upregulated by retinoids during APL cell maturation, a role for Jem in the regulation of cell growth and/or dierentiation remains to be established. However, the structural homologies predicted from the primary structure suggest a regulatory function. Tumour cell responses to retinoids are clearly in¯uenced by multiple signalling pathways (reviewed by Gudas et al., 1994; Hong and Itri, 1994 ) and this characteristic alone underlines the importance of further study to determine whether or not Jem is involved in transcriptional cross-talk. At this point of the discussion, it is noteworthy to mention several studies which are contributing to elucidate reciprocal in¯uences between retinoids and AP-1 signallings (Nicholson et al., 1990; Yang-Yen et al., 1991; Shule et al., 1991; Salbert et al., 1993; Doucas et al., 1993; Fanjul et al., 1994; Chen et al., 1995) . We speculate that JEM could be an eector in this regulation and as such, features a novel important pharmacological target.
Materials and methods

Cell lines
NB4 cell line was cultured and treated with all-trans RA as previously described (Lanotte et al., 1991) . The isolation and characterization of the maturation resistant cell line NB4-R1 have been previously reported (Duprez et al., 1992 (Duprez et al., , 1996 Ruchaud et al., 1994) .
Dierential display, cloning and sequencing RNA were extracted using standard protocol (Chomczynski and Sacchi, 1987) followed by CsCl gradient centrifugation for puri®cation. Poly(A) + RNA were puri®ed using oligo-dT cellulose column (Boehringer). cDNAs were prepared from 0.5 mg poly(A) + RNA, as independent duplicates using standard protocols. PCR ampli®cations (duplicated) were carried out with Taq polymerase (Cetus; Perkin-Elmer), essentially as described by Liang and Pardee (1992) and 30 ampli®cation cycles. Dierentially ampli®ed products, detected after electrophoretic gel migration and autoradiography, were extracted, eluted and reampli®ed by PCR. The second ampli®cation product was puri®ed on a 1% agarose gel and ligated into a pGEM-T vector (Promega). The sequences of the puri®ed recombinant plasmid were carried out using the dideoxynucleotide termination method with T7 Sequencing Kit (Pharmacia).
Preparation of NB4 cell cDNA libraries and screening
Libraries were prepared from RA-treated NB4 and NB4-R1 cell mRNAs using the`ZAP-cDNA Synthesis kit' from Stratagene (primary library of 1.5 10 6 p.f.u.). The screening of the libraries was performed by hybridization of the phage DNA transferred on Hybond nitrocellulose membrane (Amersham) with the labelled cDNA fragment (`random-priming' kit, Pharmacia) cloned from differential display. After a serial screening and amapli®cation of plasmids with positive insert, inserts were sequenced as described above. Sequences were analysed with the MacVector program, and homologies were searched in the GenBank and EMBL data bases.
Southern blot hybridization and FISH analyses
For Southern blot analysis, DNA from NB4 and HL60 cells was extracted using the standard phenol-chloroform protocol. DNA were digested with two restriction enzymes (HindIII and EcoRI), separated on electrophoretic gels, transferred to a Nylon membranes (Hybond N; Amersham) and hybridised to a 32 P-labelled probe corresponding to the PCR-ampli®ed cDNA fragment. For Southern blot analysis of JEM in DNA from various animal species, DNA extracts were digested with EcoRI, processed as described above and hybridised to a 32 P-labelled probe corresponding to a 2 kb JEM cDNA fragment.
The FISH method for chromosome localisation was performed as previously described (Cherif et al., 1990) . The Jem cDNA probe was labelled with Bio-11-UTP by random priming, and hybridised to normal human metaphase chromosomes. The hybridisation signal was revealed by avidin-conjugated¯uorescence isocyanate, the chromosomes counterstained with propidium iodide, and Rbands prepared.
Northern blot analysis
Northern blot analysis of JEM transcript in NB4 and NB4-R1 cells following RA treatment. Cells were cultured as previously described (Lanotte et al., 1991; Ruchaud et al., 1994) . RNAs were extracted (as described above), electro- Jem-1 nuclear factor cDNA E Duprez et al phoresed, transferred on Nylon-N membranes, then hybridized to a 32 P-labelled JEM cDNA fragment. cDNA probes were labelled with a`random-priming' kit (Pharmacia).
In vitro transcription-translation, in vivo transient expression in Cos-7 cells, in situ nuclear localisation of Jem protein
In vitro transcription-translation was carried out with the T3 RNA polymerase and rabbit reticulocyte lysate mixture (Promega) supplemented with [
35 S]methionine for 60 min at 308C. One mg of puri®ed plasmid cDNA was used as template. Labelled translation products were analysed on 10% SDS ± PAGE according to Laemmli. Dried gels were then processed to autoradiography.
Jem cDNA was subcloned in a eukaryotic expression vector (gift from Dr J Ghysdael), fusing the N-terminal end of Jem in frame with a 10 a.a. hemagglutinin epitope (MYDVPDYASL). Cos 7 cells were transfected by the calcium phosphate precipitation method. For Western blot analysis, the nitrocellulose membrane blotted after SDS ± PAGE of COS-cell extracts was incubated with the antihemagglutinin monoclonal antibody (Boehringer). Detection was performed using an ECL western blotting system (Amersham). For in situ localisation, the tagged-protein Jem were identi®ed by immuno-¯uorescence confocal microscopy using the anti-hemagglutinin monoclonal antibody (Boehringer).
Abbreviations APL, acute promyelocytic leukaemia; AP-1, Fos/Jun transcription factor complex; C/EBP, CCAAT-enhancer binding protein; CREB, cAMP responsive element binding protein; FISH, Fluorescence in situ hybridization; PCR, polymerase chain reaction; PKA, cAMP-dependant protein kinase; PKC, protein kinase C; RA, retinoic acid; SP-1, sequence speci®c transcription factor; UTR, untranslated terminal region
